Adjuvant low-dose interleukin-2 (IL-2) plus interferon-α (IFN-α) in operable renal cell carcinoma (RCC): a phase III, randomized, multicentre trial of the Italian Oncology Group for Clinical Research (GOIRC).
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Federico Alberici Rodolfo Passalacqua Camillo Porta Gianluca Tomasello |
| Publication date | November 1, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |